Skip to main content
David Platt, MD, Pulmonology, East Hanover, NJ

David Matthew Platt MD

Critical Care Medicine


Vice President and Head, Cardiovascular, Renal & Metabolism Medical Unit, US Clinical Development and Medical Affairs, Novartis

Join to View Full Profile
  • One Health PlazaEast Hanover, NJ 07936

Dr. Platt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2007
  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterResidency, Internal Medicine, 2001 - 2004
  • Boston University School of Medicine
    Boston University School of MedicineClass of 2001

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2004 - 2025

Publications & Presentations

PubMed

Press Mentions

  • Nature Reviews Drug Discovery Article Offers Independent Support for ProLectin-I in Fibrosis and ProLectin-M as an Antiviral Drug
    Nature Reviews Drug Discovery Article Offers Independent Support for ProLectin-I in Fibrosis and ProLectin-M as an Antiviral DrugFebruary 22nd, 2023
  • Galectin Antagonist Use in Mild Cases of SARS-CoV-2: Pilot Feasibility Randomised, Open Label, Controlled Trial Alben Sigamani1*, Mathu Ruthra1, Sudhishma1, Samarth Shetty2, Madhavi2, Anup Chugani3, Hana Chen-Walden4, David Platt4, Thomas Kutty5
    Galectin Antagonist Use in Mild Cases of SARS-CoV-2: Pilot Feasibility Randomised, Open Label, Controlled Trial Alben Sigamani1*, Mathu Ruthra1, Sudhishma1, Samarth Shetty2, Madhavi2, Anup Chugani3, Hana Chen-Walden4, David Platt4, Thomas Kutty5December 8th, 2020
  • Bioxytran Names Leslie Ajayi as Interim CMO and Head of the Medical Advisory Board
    Bioxytran Names Leslie Ajayi as Interim CMO and Head of the Medical Advisory BoardAugust 1st, 2023

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: